Evidence map›Paper›PMID 23555453›Full record

ArticleAnnals of vascular diseases2011

Enhanced neovascular formation in a novel hydrogel matrix consisting of citric Acid and collagen.

Mikiko Nagayoshi, Tetsushi Taguchi, Hiroyuki Koyama, Tsuyoshi Takato, Tetsuro Miyata, Hirokazu Nagawa

Open access · hybridAbstract read
In one paragraph

Article in Annals of vascular diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Mikiko NagayoshiDivision of Vascular Surgery, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan ; Division of Tissue Engineering, The University of Tokyo Hospital, Tokyo, Japan.
Tetsushi Taguchi
Hiroyuki Koyama
Tsuyoshi Takato
Tetsuro Miyata
Hirokazu Nagawa
The University of Tokyo · JPNational Institute for Materials Science · JPUniversity of Tokyo Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThree-dimensional regenerative tissue with large bulk generally requires blood perfusion through a vascular network to maintain its viability, and one promising approach is induction of neovascular growth from the recipient bed into the tissue. To induce ingrowth of a vascular network, it is necessary to furnish the regenerative tissue with a scaffold structure for neovasculature and a delivery system for an angiogenic growth factor. As such a scaffold structure, the present study created novel hydrogel materials by chemically cross-linking alkali-treated collagen (AlCol) with trisuccinimidyl citrate (TSC). MATERIALS AND

methodsMany prototypes, consisting of several concentrations of TSC and AlCol, were implanted into the subfascial space of the rat rectus muscle, and 7 days later, the implanted materials were excised for histological analysis. Cross-sections were stained and neovascular development in the materials was evaluated by measuring vessel density, length and number of joints and branches.

resultsSignificant ingrowth of vascularized granulation was observed in some materials, which surpassed the angiogenic ability of Matrigel(TM). Further, combination with basic fibroblast growth factor (bFGF) significantly increased the vascular formation in these gels.

conclusionsThe TSC-AlCol gel functioned as a favorable scaffold for neovascular formation and also as a reservoir for controlled delivery of bFGF.

Indexed as

basic fibroblast growth factorcitric acidcollagenhydrogelneovasucular formation

Identifiers

PMID23555453
PMCPMC3595800
OpenAlexW2016882761

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.